Synapse

← George Thanassoulis

Papers by George Thanassoulis

Page 2 · newest first

  1. Multiancestry Genome-Wide Association Study of Aortic Stenosis Identifies Multiple Novel Loci in the Million Veteran ProgramCirculation · 2023
  2. Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneityEuropean Heart Journal · 2023
  3. Canadian Cardiovascular Harmonized National Guideline Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2022 updateCanadian Medical Association Journal · 2022
  4. Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart DiseaseClinical Chemistry · 2022
  5. Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular RiskJournal of the American Heart Association · 2022
  6. High-Density Lipoprotein and Long-Term Incidence and Progression of Aortic Valve Calcification: The Multi-Ethnic Study of AtherosclerosisArteriosclerosis Thrombosis and Vascular Biology · 2022
  7. Sex Differences in Clopidogrel Effects Among Young Patients With Acute Coronary Syndrome: A Role for Genetics?CJC Open · 2022
  8. Impact of outcome definitions on cardiovascular risk prediction in a contemporary primary prevention populationEuropean Heart Journal - Quality of Care and Clinical Outcomes · 2022
  9. An adverse lipoprotein phenotype—hypertriglyceridaemic hyperapolipoprotein B—and the long-term risk of type 2 diabetes: a prospective, longitudinal, observational cohort studyThe Lancet Healthy Longevity · 2022
  10. Intersecting Genetics of Frailty and Cardiovascular DiseaseThe journal of nutrition health & aging · 2021
  11. Utility of Genetically Predicted Lp(a) (Lipoprotein [a]) and ApoB Levels for Cardiovascular Risk AssessmentCirculation Genomic and Precision Medicine · 2021
  12. Atherothrombotic factors and atherosclerotic cardiovascular events: the multi-ethnic study of atherosclerosisEuropean Heart Journal · 2021
  13. Progress and Research Priorities in Imaging Genomics for Heart and Lung Disease: Summary of an NHLBI WorkshopCirculation Cardiovascular Imaging · 2021
  14. A Comparison of Lipids and apoB in Asian Indians and AmericansGlobal Heart · 2021
  15. Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels—Brief ReportArteriosclerosis Thrombosis and Vascular Biology · 2020
  16. Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart StudyJournal of the American Heart Association · 2020
  17. The Expected 30-Year Benefits of Early Versus Delayed Primary Prevention of Cardiovascular Disease by Lipid LoweringCirculation · 2020
  18. Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humansHeart · 2020
  19. Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve StenosisJACC Basic to Translational Science · 2020
  20. A Patient-Led Referral Strategy for Cardiovascular Screening of Family and Household Members at the Time of Cardiac Intensive Care Unit AdmissionCJC Open · 2020
  21. FADS1 (Fatty Acid Desaturase 1) Genotype Associates With Aortic Valve FADS mRNA Expression, Fatty Acid Content and CalcificationCirculation Genomic and Precision Medicine · 2020
  22. Calibration and discrimination of the Framingham Risk Score and the Pooled Cohort EquationsCanadian Medical Association Journal · 2020
  23. Primary Staphylococcus aureus PericarditisCanadian Journal of General Internal Medicine · 2020
  24. Association of FADS1/2 Locus Variants and Polyunsaturated Fatty Acids With Aortic StenosisJAMA Cardiology · 2020
  25. Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetesCardiovascular Diabetology · 2020
  26. Apolipoprotein B Particles and Cardiovascular DiseaseJAMA Cardiology · 2019
  27. Mortality Benefit of Alirocumab: A Bayesian PerspectiveJournal of the American Heart Association · 2019
  28. Cost-effectiveness of Low-density Lipoprotein Cholesterol Level–Guided Statin Treatment in Patients With Borderline Cardiovascular RiskENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2019
  29. Incidence and Predictors of Intracardiac Thrombus on Pre-electrophysiological Procedure Transesophageal EchocardiographyCJC Open · 2019
  30. Genetic Variation in LPA, Calcific Aortic Valve Stenosis in Patients Undergoing Cardiac Surgery, and Familial Risk of Aortic Valve MicrocalcificationJAMA Cardiology · 2019
  31. Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed TomographyCJC Open · 2019
  32. Genetic inhibition of PCSK9 , atherogenic lipoprotein concentrations, and calcific aortic valve stenosis2019
  33. Race-Based Differences in Lipoprotein(a)-Associated Risk of Carotid AtherosclerosisArteriosclerosis Thrombosis and Vascular Biology · 2019
  34. Risk factors for valvular calcificationCurrent Opinion in Endocrinology Diabetes and Obesity · 2019
  35. A Long-term Benefit Approach vs Standard Risk-Based Approaches for Statin Eligibility in Primary PreventionJAMA Cardiology · 2018
  36. Hypertriglyceridemia and cardiovascular risk: a cautionary note about metabolic confoundingSHILAP Revista de lepidopterología · 2018
  37. Gene Expression and Proteomic Profiling of Lp (a)-Induced Signalling Pathways in Human Aortic Valve Interstitial CellsJournal of Pharmacogenomics & Pharmacoproteomics · 2018
  38. Association of LPA Variants With Aortic StenosisJAMA Cardiology · 2017
  39. Evaluation of the Pleiotropic Effects of StatinsArteriosclerosis Thrombosis and Vascular Biology · 2017
  40. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocolBMC Infectious Diseases · 2017
  41. The Benefit Model for Prevention of Cardiovascular DiseaseJAMA Cardiology · 2017
  42. Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell CalcificationJACC Basic to Translational Science · 2017
  43. Lipoprotein(a): new insights from modern genomicsCurrent Opinion in Lipidology · 2017
  44. Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis—Brief ReportArteriosclerosis Thrombosis and Vascular Biology · 2016
  45. Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein CholesterolJournal of the American Heart Association · 2016
  46. Risk of Premature Cardiovascular Disease vs the Number of Premature Cardiovascular EventsJAMA Cardiology · 2016
  47. Association Between Family History, a Genetic Risk Score, and Severity of Coronary Artery Disease in Patients With Premature Acute Coronary SyndromesArteriosclerosis Thrombosis and Vascular Biology · 2016
  48. Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)Journal of the American Heart Association · 2016
  49. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular DiseaseCirculation · 2016
  50. Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black IndividualsArteriosclerosis Thrombosis and Vascular Biology · 2016